N. Kleine

发表

Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I diabetic patients

J. Holst, M. Nauck, W. Creutzfeldt, 1996, Diabetes Care.

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients

J. Holst, M. Nauck, W. Creutzfeldt, 1993, Diabetologia.

Experimental and clinical pharmacology

J. Holst, D. Drucker, M. Nauck, 2008 .

Preserved GLP-1 effects in a diabetic patient with Cushing's disease.

J. Holst, W. Schmiegel, M. Nauck, 2007, Experimental and clinical endocrinology & diabetes.